← Leaderboards
Yuchen Qiu
University Of Oklahoma
$904,811
Attributed
$904,811
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $244.9K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$904,811 · 1
By mechanism
P20$904,811 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Diagnosis”
- David Annett · Information Management Services, Inc.$35,571,865
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- John Alam · Eip Pharma, Inc.$10,411,018
Research focus
DiagnosisDeep Neural NetworkAlgorithmsBrca MutationsCa-125 AntigenBayesian ModelingBiological MarkersCancer ImagingCancer PatientCancer PrognosisCancer TherapyCharacteristicsChemotherapyCancer CellCancer CenterClinical PracticeCollegeComputer Aided DetectionConfusionData AnalysesDatabasesData SetDecision MakingDigital
Grant awards (4)
Early Evaluation of Ovarian Cancer Prognosis by Fusing Radiographic and Histopathologic Imaging Information$202,253
P20 · FY2025 · GM · contact PI
Early Evaluation of Ovarian Cancer Prognosis by Fusing Radiographic and Histopathologic Imaging Information$228,844
P20 · FY2024 · GM · contact PI
Early Evaluation of Ovarian Cancer Prognosis by Fusing Radiographic and Histopathologic Imaging Information$228,844
P20 · FY2023 · GM · contact PI
Early Evaluation of Ovarian Cancer Prognosis by Fusing Radiographic and Histopathologic Imaging Information$244,870
P20 · FY2022 · GM · contact PI